Envista Holdings Corporation $NVST Shares Sold by XTX Topco Ltd

XTX Topco Ltd trimmed its holdings in Envista Holdings Corporation (NYSE:NVST) by 5.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 42,719 shares of the company’s stock after selling 2,415 shares during the period. XTX Topco Ltd’s holdings in Envista were worth $835,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of NVST. Alliancebernstein L.P. grew its stake in Envista by 1,985.1% during the 1st quarter. Alliancebernstein L.P. now owns 4,550,789 shares of the company’s stock valued at $78,547,000 after acquiring an additional 4,332,541 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Envista by 24.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company’s stock worth $144,760,000 after purchasing an additional 1,625,206 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of Envista by 16.7% during the 2nd quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock worth $175,011,000 after purchasing an additional 1,284,767 shares during the last quarter. Trexquant Investment LP grew its position in shares of Envista by 243.7% in the first quarter. Trexquant Investment LP now owns 1,065,849 shares of the company’s stock valued at $18,397,000 after purchasing an additional 755,725 shares in the last quarter. Finally, Gates Capital Management Inc. increased its holdings in shares of Envista by 10.0% in the first quarter. Gates Capital Management Inc. now owns 5,163,745 shares of the company’s stock valued at $89,126,000 after purchasing an additional 469,597 shares during the last quarter.

Envista Stock Down 0.7%

NYSE:NVST opened at $20.76 on Tuesday. Envista Holdings Corporation has a 52 week low of $14.22 and a 52 week high of $22.68. The stock’s fifty day moving average is $20.09 and its two-hundred day moving average is $19.93. The stock has a market capitalization of $3.41 billion, a price-to-earnings ratio of 64.86, a price-to-earnings-growth ratio of 1.09 and a beta of 1.05. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. Envista had a return on equity of 4.84% and a net margin of 2.11%.The firm had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. During the same quarter in the previous year, the business earned $0.12 EPS. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. Research analysts anticipate that Envista Holdings Corporation will post 1 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Mizuho set a $19.00 price objective on Envista in a research note on Monday, November 3rd. Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 1st. Robert W. Baird set a $27.00 price objective on shares of Envista in a report on Friday, October 31st. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 15th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Envista in a report on Monday, November 24th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Envista presently has an average rating of “Hold” and an average price target of $21.33.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.